CD36负性调控TFEB-自噬溶酶体通路参与糖尿病肾病的发生发展
结题报告
批准号:
31971084
项目类别:
面上项目
资助金额:
57.0 万元
负责人:
陈曜
依托单位:
学科分类:
营养与代谢生理学
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
陈曜
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
白细胞分化抗原36(CD36)属于B型清道夫受体家族,是调控机体免疫和代谢稳态的重要分子。我们和其他课题组的前期工作表明:糖尿病肾病(DN)的患者和动物模型中,肾脏CD36表达升高,且与肾损伤呈正相关;CD36缺失可以改善DN小鼠的肾脏病变和肾功能降低。.自噬-溶酶体通路受损在DN发生发展中起到关键作用。我们前期发现:抑制CD36可以促进转录因子EB (TFEB)的核转位,改善自噬-溶酶体功能。因此,本项目拟在大量前期工作基础上,从人群、动物模型和细胞模型三个层次,全面深入研究CD36在DN病变中的作用,并探讨CD36负性调控TFEB-自噬溶酶体通路参与DN发生发展的分子机制,这将加深人们对DN发病机制的认识,可能为临床上有效防治DN提供新的靶点。
英文摘要
CD36 is a multi-functional class B scavenger receptor, which acts as an important modulator of lipid homeostasis and immune responses. Previously, we and other groups have demonstrated that CD36 expression was significantly increased in kidneys from patients with DN and DN animal models. Furthermore, CD36 deficiency protected mice from kidney injury in a STZ/HFD-induced DN model. Thus, these data supported that CD36 plays a key role in the development and progression of DN..Autophagy is an evolutionary-conserved lysosomal-mediated protein degradation process that cells use to remove protein aggregates and damaged or excess organelles. Impairment of autophagic flux is closely related to the development and progression of glomerulosclerosis, kidney fibrosis and diabetic nephropathy. We have also observed that CD36 deficiency enhanced autophagic flux in kidneys from STZ/HFD-induced DN mice. Transcription factor EB (TFEB) is a master gene for autophagy, which coordinates expression of lysosomal hydrolases, multiple membrane proteins and genes involved in autophagy. We found that while knockdown of CD36 expression promoted TFEB translocation into nucleus of HK2 cells, CD36 overexpression hindered TFEB from translocation into nucleus. Therefore, we hypothesize that CD36 negatively regulates TFEB pathway, inducing autophagic impairement. Following this line, in this project, we plan to verify the importance of CD36 in DN patients and animal models. Moreover, we will investigate whether CD36 causes DN via impairing TFEB-regulated autophagic process and explore the underlying mechanisms.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1016/j.bbadis.2023.166800
发表时间:2023-07
期刊:Biochimica et biophysica acta. Molecular basis of disease
影响因子:--
作者:Yuqi Li;Linkun Zhang;Junkui Jiao;Qiuying Ding;Yanping Li;Zhibo Zhao;Jinfeng Luo;Yaxi Chen;Xiongzhong Ruan;Lei Zhao
通讯作者:Yuqi Li;Linkun Zhang;Junkui Jiao;Qiuying Ding;Yanping Li;Zhibo Zhao;Jinfeng Luo;Yaxi Chen;Xiongzhong Ruan;Lei Zhao
DOI:10.3389/fphys.2021.669279
发表时间:2021
期刊:Frontiers in physiology
影响因子:4
作者:Zhao L;Li Y;Ding Q;Li Y;Chen Y;Ruan XZ
通讯作者:Ruan XZ
DOI:10.1016/j.yexcr.2020.112438
发表时间:2021-01-06
期刊:EXPERIMENTAL CELL RESEARCH
影响因子:3.7
作者:Yu, Ting;Zheng, Enze;Chen, Yaxi
通讯作者:Chen, Yaxi
Obesity induces preadipocyte CD36 expression promoting inflammation via the disruption of lysosomal calcium homeostasis and lysosome function
肥胖诱导前脂肪细胞 CD36 表达,通过破坏溶酶体钙稳态和溶酶体功能促进炎症
DOI:10.1016/j.ebiom.2020.102797
发表时间:2020-06-01
期刊:EBIOMEDICINE
影响因子:11.1
作者:Luo, Xiaoxiao;Li, Yanping;Chen, Yaxi
通讯作者:Chen, Yaxi
DOI:10.3389/fbioe.2022.841034
发表时间:2022
期刊:FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
影响因子:5.7
作者:Ding, Qiuying;Hou, Zhengping;Zhao, Zhibo;Chen, Yao;Zhao, Lei;Xiang, Yue
通讯作者:Xiang, Yue
肝细胞CD36通过UBQLN1介导的自噬体—溶酶体融合障碍调控脓毒症急性肝损伤
  • 批准号:
    82241040
  • 项目类别:
    专项项目
  • 资助金额:
    62.00万元
  • 批准年份:
    2022
  • 负责人:
    陈曜
  • 依托单位:
干预FAT/CD36对mTOR信号通路激活介导的肝胰岛素抵抗的影响及机制研究
  • 批准号:
    31571210
  • 项目类别:
    面上项目
  • 资助金额:
    63.0万元
  • 批准年份:
    2015
  • 负责人:
    陈曜
  • 依托单位:
炎症干扰肝X受体及其靶基因导致肝细胞脂质异常积聚的分子机制
  • 批准号:
    81070317
  • 项目类别:
    面上项目
  • 资助金额:
    32.0万元
  • 批准年份:
    2010
  • 负责人:
    陈曜
  • 依托单位:
ALR对T淋巴细胞抑制作用的分子机制研究
  • 批准号:
    30500457
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    21.0万元
  • 批准年份:
    2005
  • 负责人:
    陈曜
  • 依托单位:
国内基金
海外基金